Form 4 holding
Chief Financial Officer
NEUROCRINE BIOSCIENCES INC
- Security class
- Common Stock
- Shares / value
- 42,808
- Estimated value
- $5,949,455
- Report date
- 04 Mar 2026
- Price
- $138.98
- Ownership
- Direct
Matt Abernethy - Chief Financial Officer at NEUROCRINE BIOSCIENCES INC
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- NBIX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matt Abernethy since 05 Sep 2025
Reported holdings for Matt Abernethy in NEUROCRINE BIOSCIENCES INC
Form 4 holding
Chief Financial Officer
NEUROCRINE BIOSCIENCES INC
- Security class
- Restricted Stock Unit
- Shares / value
- 7,735
- Estimated value
- $795,399
- Report date
- 13 Feb 2026
- Price
- $118.28
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
NEUROCRINE BIOSCIENCES INC
- Security class
- Stock Option
- Shares / value
- 44,095
- Estimated value
- Report date
- 13 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matt Abernethy in NEUROCRINE BIOSCIENCES INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.